240 related articles for article (PubMed ID: 16101310)
1. DNA minor groove adducts formed by a platinum-acridine conjugate inhibit association of tata-binding protein with its cognate sequence.
Budiman ME; Bierbach U; Alexander RW
Biochemistry; 2005 Aug; 44(33):11262-8. PubMed ID: 16101310
[TBL] [Abstract][Full Text] [Related]
2. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
Barry CG; Baruah H; Bierbach U
J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
[TBL] [Abstract][Full Text] [Related]
3. Duplex-promoted platination of adenine-N3 in the minor groove of DNA: challenging a longstanding bioinorganic paradigm.
Barry CG; Day CS; Bierbach U
J Am Chem Soc; 2005 Feb; 127(4):1160-9. PubMed ID: 15669855
[TBL] [Abstract][Full Text] [Related]
4. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
Baruah H; Wright MW; Bierbach U
Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
[TBL] [Abstract][Full Text] [Related]
5. Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.
Guddneppanavar R; Bierbach U
Anticancer Agents Med Chem; 2007 Jan; 7(1):125-38. PubMed ID: 17266509
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
[TBL] [Abstract][Full Text] [Related]
7. Metal-intercalator-mediated self-association and one-dimensional aggregation in the structure of the excised major DNA adduct of a platinum-acridine agent.
Baruah H; Day CS; Wright MW; Bierbach U
J Am Chem Soc; 2004 Apr; 126(14):4492-3. PubMed ID: 15070347
[TBL] [Abstract][Full Text] [Related]
8. Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.
Budiman ME; Alexander RW; Bierbach U
Biochemistry; 2004 Jul; 43(26):8560-7. PubMed ID: 15222767
[TBL] [Abstract][Full Text] [Related]
9. Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents.
Rao L; West TK; Saluta G; Kucera GL; Bierbach U
Chem Res Toxicol; 2010 Jul; 23(7):1148-50. PubMed ID: 20578739
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the bisintercalative DNA binding mode of a bifunctional platinum-acridine agent.
Choudhury JR; Bierbach U
Nucleic Acids Res; 2005; 33(17):5622-32. PubMed ID: 16192574
[TBL] [Abstract][Full Text] [Related]
11. DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers.
Suryadi J; Bierbach U
Chemistry; 2012 Oct; 18(41):12926-34. PubMed ID: 22987397
[TBL] [Abstract][Full Text] [Related]
12. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.
Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M
Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685
[TBL] [Abstract][Full Text] [Related]
13. Unusual intercalation of acridin-9-ylthiourea into the 5'-GA/TC DNA base step from the minor groove: implications for the covalent DNA adduct profile of a novel platinum-intercalator conjugate.
Baruah H; Bierbach U
Nucleic Acids Res; 2003 Jul; 31(14):4138-46. PubMed ID: 12853631
[TBL] [Abstract][Full Text] [Related]
14. Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.
Hess SM; Mounce AM; Sequeira RC; Augustus TM; Ackley MC; Bierbach U
Cancer Chemother Pharmacol; 2005 Oct; 56(4):337-43. PubMed ID: 15895232
[TBL] [Abstract][Full Text] [Related]
15. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
[TBL] [Abstract][Full Text] [Related]
16. Guanine binding of a cytotoxic platinum-acridin-9-ylthiourea conjugate monitored by 1-D 1H and 2-D [1H,15N] NMR spectroscopy: hydrolysis is not the rate-determining step.
Guddneppanavar R; Wright MW; Tomsey AK; Bierbach U
J Inorg Biochem; 2006 May; 100(5-6):972-9. PubMed ID: 16488016
[TBL] [Abstract][Full Text] [Related]
17. Sequence-dependent solution structure and motions of 13 TATA/TBP (TATA-box binding protein) complexes.
Strahs D; Barash D; Qian X; Schlick T
Biopolymers; 2003 Jun; 69(2):216-43. PubMed ID: 12767124
[TBL] [Abstract][Full Text] [Related]
18. Presence of the anti-leukemic nucleotide analog, 2-chloro-2'-deoxyadenosine-5'-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP).
Hartman WR; Walters DE; Hentosh P
Arch Biochem Biophys; 2007 Mar; 459(2):223-32. PubMed ID: 17320040
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
Zhai X; Beckmann H; Jantzen HM; Essigmann JM
Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
[TBL] [Abstract][Full Text] [Related]
20. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
